Benjamin Berger

640 total citations
23 papers, 518 citations indexed

About

Benjamin Berger is a scholar working on Pharmacology, Endocrine and Autonomic Systems and Cognitive Neuroscience. According to data from OpenAlex, Benjamin Berger has authored 23 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Endocrine and Autonomic Systems and 6 papers in Cognitive Neuroscience. Recurrent topics in Benjamin Berger's work include Pharmacogenetics and Drug Metabolism (7 papers), Sleep and related disorders (6 papers) and Sleep and Wakefulness Research (6 papers). Benjamin Berger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Sleep and related disorders (6 papers) and Sleep and Wakefulness Research (6 papers). Benjamin Berger collaborates with scholars based in Switzerland, Tanzania and United States. Benjamin Berger's co-authors include Manuel Haschke, Stephan Krähenbühl, Urs Duthaler, Massimiliano Donzelli, Jasper Dingemanse, Bernard B. Brodie, E. M. Papper, Michael McCally, Franziska Boess and Adrian Roth and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Benjamin Berger

23 papers receiving 489 citations

Peers

Benjamin Berger
P. Jacob United States
Benito J. Cerimele United States
AF Cohen Netherlands
Ram P. Kapil United States
Donald Stanski United States
Jennifer A. Graf United States
Benjamin Berger
Citations per year, relative to Benjamin Berger Benjamin Berger (= 1×) peers Herman van Wietmarschen

Countries citing papers authored by Benjamin Berger

Since Specialization
Citations

This map shows the geographic impact of Benjamin Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Berger more than expected).

Fields of papers citing papers by Benjamin Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Berger. The network helps show where Benjamin Berger may publish in the future.

Co-authorship network of co-authors of Benjamin Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Berger. A scholar is included among the top collaborators of Benjamin Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Berger. Benjamin Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Benjamin, et al.. (2024). Value of Assessing 1‐Hydroxymidazolam in Drug‐Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A. The Journal of Clinical Pharmacology. 64(9). 1123–1129. 2 indexed citations
2.
Dingemanse, Jasper, Stéphane Delahaye, Luboš Janů, et al.. (2023). Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT‐1014‐6470 in vitro and in vivo. Clinical and Translational Science. 16(7). 1220–1231. 2 indexed citations
4.
Berger, Benjamin, Jasper Dingemanse, Stéphane Delahaye, et al.. (2021). Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist. Clinical Pharmacokinetics. 60(10). 1349–1360. 17 indexed citations
5.
Berger, Benjamin, et al.. (2021). Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects. European Neuropsychopharmacology. 51. 90–104. 12 indexed citations
6.
Berger, Benjamin, et al.. (2021). Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment. Clinical and Translational Science. 14(6). 2132–2138. 16 indexed citations
8.
Berger, Benjamin, Priska Kaufmann, Annelize Koch, & Jasper Dingemanse. (2020). Impact of the Selective Orexin‐1 Receptor Antagonist ACT‐539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects. The Journal of Clinical Pharmacology. 60(7). 931–941. 10 indexed citations
9.
Berger, Benjamin, et al.. (2018). Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug. Frontiers in Pharmacology. 9. 774–774. 52 indexed citations
10.
Duthaler, Urs, Benjamin Berger, Stefan Erb, et al.. (2018). Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions. Journal of Antimicrobial Chemotherapy. 73(10). 2729–2737. 16 indexed citations
11.
Duthaler, Urs, Benjamin Berger, Stefan Erb, et al.. (2017). Automated high throughput analysis of antiretroviral drugs in dried blood spots. Journal of Mass Spectrometry. 52(8). 534–542. 26 indexed citations
12.
Erb, Stefan, Emílio Letang, Tracy R. Glass, et al.. (2017). Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems. HIV Medicine. 18(9). 623–634. 13 indexed citations
13.
Berger, Benjamin, Massimiliano Donzelli, Franziska Boess, et al.. (2016). Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail. Frontiers in Pharmacology. 7. 443–443. 68 indexed citations
14.
Berger, Benjamin, et al.. (2016). CombiCap: A novel drug formulation for the basel phenotyping cocktail. International Journal of Pharmaceutics. 512(1). 253–261. 12 indexed citations
15.
Derungs, Adrian, et al.. (2015). Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study. Clinical Pharmacokinetics. 55(1). 79–91. 45 indexed citations
16.
17.
Berger, Benjamin, et al.. (2006). Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. British Journal of Pharmacology. 148(6). 795–806. 42 indexed citations
18.
McCally, Michael, et al.. (1980). Case mix in HMOs and fee-for-service systems: The ratio of routine visits to total visits in adult primary care. PubMed. 14(4). 267–273. 6 indexed citations
19.
McCally, Michael, et al.. (1980). New Health Professions After a Decade and a Half: Delegation, Productivity, and Costs in Primary Care. Journal of Health Politics Policy and Law. 5(3). 470–497. 44 indexed citations
20.
Berger, Benjamin, et al.. (1955). THE PHYSIOLOGICAL DISPOSITION AND FATE OF MEPERIDINE (DEMEROL) IN MAN AND A METHOD FOR ITS ESTIMATION IN PLASMA. Journal of Pharmacology and Experimental Therapeutics. 114(3). 289–298. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026